Showing 1 - 10 of 686
note we present a specific risk sharing agreement on effectiveness and show how such mechanism is going to affect the … market in the long run. In particular, we will show how the regulator may create a trade off between expected efficacy and …
Persistent link: https://www.econbiz.de/10014217551
In this article we analyse the problem of determining the price for new drugs in a market where a stringent budget constraint on public expenditure exists and we suggest an innovative methodology to set their prices. The market is characterised by asymmetry of information and a high proportion...
Persistent link: https://www.econbiz.de/10014071880
In this article we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already...
Persistent link: https://www.econbiz.de/10014028693
Persistent link: https://www.econbiz.de/10010207164
The Covid-19 pandemic has brought renewed attention to rationing guidelines for scarce medical resources. This paper describes the benefits of using a reserve system over a priority system in operationalizing compromises between certain ethical goals. In the last two years, more than a dozen...
Persistent link: https://www.econbiz.de/10013210092
's prices reflecting their relative effectiveness send the right signal to the industry - rewarding innovation with impact on …-tiered co-payments for users (avoidable and inversely related with the incremental effectiveness of de drug) are deemed …
Persistent link: https://www.econbiz.de/10014061473
The trade-off between property rights/price regulation and innovation depends on country characteristics and drug industry specificities. Access to drugs and innovation can be reconciled by seven ways that, among others, include: public health strengthening in the countries with the largest...
Persistent link: https://www.econbiz.de/10014070742
unprecedented consequences on different aspects of economies. Notwithstanding different approaches to measure the effectiveness of … COVID-19 vaccines in clinical medicines, this paper sheds new light on the efficacy of COVID-19 vaccines by using the …
Persistent link: https://www.econbiz.de/10012650179
Markets require informed participants to function efficiently. This paper examines the impact of providing targeted information directly to patients on their purchasing-decisions regarding pharmaceutical drugs. We analyze the effect of informational letters sent by a Swiss health insurer to...
Persistent link: https://www.econbiz.de/10014564096
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791